Vivos Inc (RDGL)

[Popeye]

Not at all.

Cadwell's preferred's break even at 1.5 cents upon conversion so the stock is going to have to be at least that prior to r/s. Preferred shareholders will vote on the r/s and who owns the most of that vote? Cadwell.

He won't vote to lose money. The r/s won't happen until we're sitting at 2 to 3 cents and in my opinion, if it doesn't get there - then they'll wait. Cadwell is essentially my insurance policy here.

If the company was in the same shape this year as it was last year, I'd be tracking with all you say - but there is majorly good stuff happening now and this is no longer and FDA and pray scenario.

Vet commercializing is what I'm most interested in. That's why I'm still in this and The market and opportunity is a lot bigger than what most people see. I admit it doesn't sound as glamorous as saving a human life (which will come with FDA), which is probably why the vet oncology market doesn't get much attention but that creates a very good opportunity for Radiogel and ADMD.

Why all the sudden vet? Well it's not all the sudden. When the FDA denied last year I was in shock. We all were. I PM'd you many many times and you went completely dark and I was honestly very concerned until you recently came back to the board. In the interview shortly after the denial Jim spent about 25% of the time talking about vet and how they will pursue and activate that market. I found hope in that and some other things he said so instead of selling off my position on the bounce, I held and loaded up.

Then FDA meetings took place, Isotherapeutics got hired, meetings with cyberknife and then BOOM - Dr. Alice on the board and Radiogel going into Vet market turned to fruition and the market reacted positively.

Much of what Jim said in the June PR and interview is coming to fruition. He even mentioned uplist and that's still the plan. They will only r/s to uplist. This is no stinky pinkie forever. I'm convinced of that.

12 million companion animals are diagnosed with cancer every year. 25% of owners are willing to spend $1,000 or more to save their pet. Radiogel will cost 1/2 to 2/3 less than chemo and the recovery time is far quicker.

If ADMD can reach just 1% of those animals with cancer that's 12,000 cases. If ADMD charged say $750 per animal and vet charges $750? That's a tolerable price to save a pet.

12k cases x $750 = $9 million in revenue.

Now obviously there's going to be ramp up time but now you know why I'm long and strong. Can you imagine what just a few million $ in revenue will do to this ticker this year in Pre-FDA mode?

OTC is a penny casino - No doubt and there's significant risk but I LOVE my chances here. I admit there are days that this ticker gives me a few extra grey hairs but so far, my gamble with betting on vet is paying dividends and if revenue starts showing up in May or June, we could possibly see silver before r/s and uplist.

GLTY

$ADMD